| Trial ID: | L2542 |
| Source ID: | NCT00198146
|
| Associated Drug: |
Zenapax
|
| Title: |
Prevention of Diabetes Progression Trial (PDPT)
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Newly Diagnosed With Type 1 Diabetes
|
| Interventions: |
DRUG: Zenapax
|
| Outcome Measures: |
Primary: Area under the curve, Glucagon Stimulation Testing for c-peptide measurements at 0, +6min and +10min intervals over 2 years | Secondary: HbA1c|Insulin requirements (units/kg/day)
|
| Sponsor/Collaborators: |
Sponsor: Indiana University School of Medicine | Collaborators: Pescovitz, Mark D., M.D.|Roche Pharma AG|Facet Biotech
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2000-07
|
| Completion Date: |
2007-02-23
|
| Results First Posted: |
|
| Last Update Posted: |
2020-08-11
|
| Locations: |
Indiana University - Riley Hospital for Children, Indianapolis, Indiana, 46202, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00198146
|
